NEW YORK (GenomeWeb News) – OncoPlex Diagnostics said today that it has received certification of accreditation from the College of American Pathologists for its clinical laboratory facility.
The company's lab offers mass spec-based quantitation of oncoproteins in tissue, providing clinicians with protein expression data to guide patient treatment decisions.
CAP accreditation is an internationally recognized certification with standards that typically exceed standard regulatory requirements. OncoPlex is now both CAP-accredited and CLIA-certified for clinical processing of formalin-fixed, paraffin-embedded cancer tissue using selected-reaction monitoring mass spectrometry.
"Clinicians ordering our assays can have confidence that the results received are of the highest quality possible," OncoPlex CEO Jon Burrows said in a statement.